The arrival of generic versions could drive market growth of 15% to 30% following expiration
Pasternak B et al
FDA and Bulk-Substance Rules BPC-157 can be bought and sold in the United States as a research chemical, as long as it is labeled and sold for laboratory research use and not for human use
Semaglutide, a glucagon-like peptide-1 (GLP-1) receptor agonist, is the active pharmaceutical ingredient in widely prescribed treatments such as Ozempic, Rybelsus, and Wegovy
Have a personal or family history of medullary thyroid carcinoma or Multiple Endocrine Neoplasia syndrome type 2: GLP-1 medications are contraindicated for these conditions
While many patients experience improved wellbeing during treatment, some may notice emotional changes linked to reduced appetite, hormone shifts, physical adjustment, or changing eating habits